Pulmonary Pressure Monitors Market Outlook: Rise in Cases of Pulmonary Hypertension & COPD to Drive Market Growth to US$ 5.55 Billion by 2033

As per the latest market research by Business Market Insights (BMI), the research report "Pulmonary Pressure Monitors Market Outlook Size and Forecast (2022–2033)" forecasts how the market is set to surge 75.2% by 2033 as growing cases of pulmonary hypertension & COPD reshape the pulmonary pressure monitors ecosystem. The report highlights technological advancements in monitoring technologies, revolutionizing the global landscape of pulmonary pressure monitors.

The report forecasts the market to expand from US$ 3.17 billion in 2024 to US$ 5.55 billion by 2033, registering a robust CAGR of 6.43% over the 2025–2033 period.

Improved​‍​‌‍​‍‌​‍​‌‍​‍‌ monitoring technologies through technological advancements are the key factors in the pulmonary pressure monitors market expansion. These advancements have greatly increased diagnostic accuracy, patient comfort, and healthcare provider efficiency. Technologies like wireless telemetry, miniaturized sensors, and real-time data analytics have revolutionized traditional invasive systems, turning them into sophisticated, integrated platforms that can monitor continuously both in a hospital and at home. Smart catheters and implantable sensors have been the major sources of pulmonary artery pressure monitoring for a long time, thus facilitating early intervention in diseases such as congestive heart failure and pulmonary hypertension. Moreover, connection with electronic health records (EHRs) and cloud-based platforms helps in the effortless exchange of data between patients and healthcare providers, thus improving care coordination and patient outcomes. AI-powered algorithms are progressively employed to understand pressure trends, thus lowering hospital readmissions and facilitating value-based care models. These innovations are gradually increasing the use of pulmonary pressure monitoring in different clinical scenarios and, at the same time, making it more affordable and extendable to various healthcare ​‍​‌‍​‍‌​‍​‌‍​‍‌settings.

Overview of report findings

Market Growth

The Pulmonary Pressure Monitors Market is projected to grow from US$ 3,17 billion in 2024 to US$ 5.55 billion by 2033, registering a compound annual growth rate (CAGR) of 6.43% between 2025 and 2033.

The growth in the cases of pulmonary hypertension & COPD, and increasing preference for remote respiratory monitoring are key factors propelling market growth. Advancements in pulmonary pressure monitoring technologies are transforming the landscape of pulmonary pressure monitors.

Growth in the Cases of Pulmonary Hypertension & COPD

The​‍​‌‍​‍‌​‍​‌‍​‍‌ increasing prevalence of pulmonary hypertension and chronic obstructive pulmonary disease (COPD) is the primary factor that boosts the pulmonary pressure monitor market. As these diseases require continuous and accurate monitoring of pulmonary artery pressure to manage the progression of the diseases and to prevent acute exacerbations, healthcare providers are increasingly implementing advanced monitoring technology. In the case of pulmonary hypertension, which is frequently linked with heart failure and systemic vascular disorders, the situation in the intensive care unit demands invasive monitoring of the pressure; meanwhile, patients with COPD benefit from the early identification of the changes in the pressure that indicate respiratory distress. The increasing load of such diseases as a result of aging populations, environmental factors, and lifestyle-related risks has caused governments and health systems to invest in pulmonary diagnostics for hospital and home care. This rise in clinical demand has been a motivation for manufacturers to innovate more accurate, minimally invasive, and connected monitoring solutions. With the increase in awareness and screening programs, especially in the population at high risk, pulmonary pressure monitors are becoming a tool for the management of chronic respiratory diseases, which facilitates their use in improving patient outcomes and reducing hospital ​‍​‌‍​‍‌​‍​‌‍​‍‌stays.

Increasing Preference for Remote Respiratory Monitoring

The​‍​‌‍​‍‌​‍​‌‍​‍‌ pulmonary pressure monitors market is being largely influenced by the preference of people for remote respiratory monitoring. Healthcare systems globally are adopting decentralized and patient-centric care models. As a result of the increase in chronic respiratory diseases such as pulmonary hypertension and COPD, monitoring has become so continuous that it is the best way for early intervention and disease management. In particular, implantable and wireless telemetry-based systems are remote pulmonary pressure monitors that enable real-time data transmission to healthcare providers. These data allow for timely adjustments in the treatment and reduce hospital readmissions. Also, this trend is being supported by the increase in telehealth platforms that easily integrate with digital monitoring devices to facilitate virtual consultations and care. Patients get the benefit of the convenience and comfort of home-based monitoring.

On the other hand, clinicians get access to comprehensive pressure trend data for informed decision-making. Besides, the COVID-19 pandemic was a major factor that led to the accelerated adoption of remote monitoring technologies, thereby confirming their importance in the management of respiratory patients who are vulnerable without exposing them to clinical environments. The demand for pulmonary pressure monitors that are designed for remote use will increase gradually as the digital health infrastructure mature.

Geographic Insights

North​‍​‌‍​‍‌​‍​‌‍​‍‌ America is the major market for pulmonary pressure monitors. This is largely due to the region's modern healthcare system, high rate of cardiopulmonary diseases, and the increased use of invasive monitoring techniques in intensive care units. The region has the advantages of excellent reimbursement plans, a dynamic clinical research environment, and a wide-scale adoption of digital health platforms that facilitate remote pulmonary monitoring. Europe is the second largest region with well-organized publicly funded healthcare systems, aging populations, and a regulatory focus on the early diagnosis of diseases and their management. On the other hand, the Asia Pacific is the most rapidly expanding region. This growth is attributable to a greater understanding of lung health, more money being spent on health care, and fast urbanization. The developing markets of China, India, and Southeast Asia are increasing the availability of diagnostic tools through public health programs and the growth of the private sector. At the same time, they are also adopting mobile and wearable devices to monitor the health of remote ​‍​‌‍​‍‌​‍​‌‍​‍‌populations.

Market Segmentation

• Based on Product, the market is segmented into invasive monitors, non-invasive monitors, oximeters, capnographs, and spirometers. The invasive monitors segment dominated the market in 2024.
• Based on End User, the market is segmented into hospitals and clinics, home-care Settings, ambulatory surgical centers, other end users. The Hospitals and Clinics dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Pulmonary Pressure Monitors Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic Plc
2. GE HealthCare Technologies Inc
3. Koninklijke Philips NV
4. Baxter International Inc
5. Terumo Corp
6. ICU Medical
7. Edwards Lifesciences

Trending Topics: Implantable pulmonary pressure sensors, Remote patient monitoring platforms, AI-powered pressure trend analysis, Wireless telemetry systems, Integration with electronic health records (EHRs), Home-based pulmonary diagnostics, Miniaturized catheter technologies, Predictive analytics for heart failure, Telehealth-enabled respiratory care, Cuffless pulmonary pressure monitoring, Cloud-based data sharing, Early detection of pulmonary hypertension, Personalized respiratory therapy, Regulatory approvals for digital monitoring devices, Expansion in outpatient cardiopulmonary care

Global Headlines

• " FDA Approves Implantable Pulmonary Pressure Sensor for Heart Failure Management - In September 2025, the​‍​‌‍​‍‌​‍​‌‍​‍‌ U.S. FDA has given its approval to a next-generation implantable pulmonary pressure sensor aimed at supporting the management of heart failure patients. The device allows uninterrupted recording of pulmonary artery pressure so that doctors can easily see the first signs of the patient's condition getting worse when they are not in the hospital and thus change the therapy ​‍​‌‍​‍‌​‍​‌‍​‍‌accordingly."

• " WHO Expands Global Initiative for Pulmonary Hypertension Screening in LMICs - In August 2025, the World Health Organization (WHO) incorporated an extra phase in its worldwide pulmonary hypertension testing enhancement program, specially designed for economically challenged countries. The initiative focuses on empowering local medical personnel through education and equipping remote healthcare centers with portable pressure ​‍​‌‍​‍‌​‍​‌‍​‍‌monitoring devices."

Conclusion

The​‍​‌‍​‍‌​‍​‌‍​‍‌ Pulmonary Pressure Monitors market is changing rapidly, which is a result of clinical demand, innovation in technology, and changes in care models. The worldwide increase in pulmonary hypertension and COPD is escalating the demand for accurate and continuous pressure monitoring, mainly in the elderly and high-risk populations. Moreover, the developments in portable and minimally invasive technologies are enabling the pulmonary pressures to be checked in hospital and home care settings in a more comfortable way. On the other hand, the rising preference for remote respiratory monitoring is increasing across outpatient and telehealth platforms. Even though there are some promising drivers, the market still faces some challenges, such as the high cost of advanced devices and concerns about data privacy and interoperability. Nevertheless, the move towards real-time pulmonary pressure monitoring and the advent of AI-powered diagnostic tools offer considerable potential in facilitating early detection, personalized care, and better clinical outcomes. With healthcare systems focusing on proactive respiratory management, the pulmonary pressure monitors market is likely to become a fundamental part of cardiopulmonary care of the ​‍​‌‍​‍‌​‍​‌‍​‍‌future.